Muscular Dystrophy: Key Concepts in Respiratory Care

Muscular dystrophy is a group of inherited disorders that cause progressive weakness and loss of skeletal muscle. Although many people first associate muscular dystrophy with difficulty walking, the disease can also affect breathing, coughing, swallowing, and airway protection.

This makes it an important condition in respiratory care. The lungs may remain relatively normal early in the disease, but the muscles that move air in and out of the lungs gradually weaken.

As a result, patients can develop ineffective cough, retained secretions, sleep-related hypoventilation, respiratory infections, and eventually chronic respiratory failure.

What Is Muscular Dystrophy?

Muscular dystrophy refers to a group of genetic muscle-wasting diseases that progressively damage skeletal muscles. These disorders are classified as myopathic diseases, which means the primary problem is located in the muscle itself rather than in the nerves that control the muscle.

In many neuromuscular disorders, the nerve signal may be abnormal or may fail to reach the muscle. In muscular dystrophy, the nerve impulse may still reach the muscle, but the diseased muscle fibers cannot respond with a normal contraction. Over time, muscle tissue degenerates, strength declines, and functional ability becomes more limited.

Muscular dystrophy can affect different muscle groups depending on the specific type. Some forms begin in early childhood, while others appear in adolescence or adulthood. Some progress rapidly, while others worsen slowly over many years. Despite these differences, many forms share one important clinical feature: they can weaken the muscles needed for breathing and airway clearance.

The respiratory system depends on several muscle groups working together. These include:

• The diaphragm
• The intercostal muscles
• Accessory muscles of inspiration
• Abdominal and expiratory muscles
• Upper airway muscles
• Bulbar muscles involved in swallowing and airway protection

When these muscles become weak, the patient may have difficulty taking deep breaths, maintaining adequate ventilation, coughing effectively, clearing secretions, and protecting the airway from aspiration.

Common Types of Muscular Dystrophy

There are several forms of muscular dystrophy that may affect respiratory function. They differ in inheritance pattern, age of onset, progression, severity, and associated complications.

Common types include:

• Duchenne muscular dystrophy
• Becker muscular dystrophy
• Myotonic dystrophy
• Facioscapulohumeral muscular dystrophy
• Limb-girdle muscular dystrophy
• Oculopharyngeal muscular dystrophy

Note: Not every patient with muscular dystrophy develops the same degree of respiratory impairment. However, respiratory monitoring is important because ventilatory decline can occur gradually and may not be obvious until the disease is advanced.

Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is one of the most clinically significant forms because it begins early in life and progresses steadily. It is caused by mutations in the dystrophin gene. Dystrophin is a protein that helps maintain normal muscle cell structure and function. When dystrophin is absent or severely abnormal, muscle fibers become fragile and progressively degenerate.

Duchenne muscular dystrophy is inherited as an X-linked recessive disorder, so it primarily affects males. Diagnosis is usually based on clinical findings and confirmed through genetic testing or muscle tissue analysis showing absent or abnormal dystrophin.

Children with Duchenne muscular dystrophy often develop proximal muscle weakness, meaning the muscles closer to the trunk are affected early. This commonly involves the pelvic and thigh muscles. Clinical findings may include a waddling gait, exaggerated lumbar curvature, difficulty climbing stairs, frequent falls, and progressive loss of walking ability. Many affected children require a wheelchair by around 12 years of age.

Respiratory decline often becomes more noticeable around the time wheelchair dependence develops because overall muscle weakness has progressed significantly. As the diaphragm, chest wall muscles, and expiratory muscles weaken, the patient becomes more vulnerable to hypoventilation, weak cough, secretion retention, atelectasis, and pneumonia.

Becker Muscular Dystrophy

Becker muscular dystrophy is closely related to Duchenne muscular dystrophy because it also involves dystrophin abnormalities. However, it is usually milder and progresses more slowly. Symptoms may begin later, and patients often maintain walking ability longer than those with Duchenne muscular dystrophy.

Respiratory involvement can still occur, especially as the disease advances. Patients may develop declining pulmonary function, sleep-related hypoventilation, weak cough, secretion retention, and recurrent respiratory infections. The timing of respiratory support varies based on symptoms, objective measurements, and the patient’s overall disease progression.

Myotonic Dystrophy

Myotonic dystrophy is the most common muscular dystrophy in adults. Its defining feature is myotonia, which means delayed muscle relaxation after contraction. It is inherited as an autosomal dominant disorder and can affect multiple body systems.

In addition to skeletal muscle weakness, myotonic dystrophy may be associated with cardiac conduction abnormalities, endocrine dysfunction, cataracts, swallowing problems, and respiratory complications. Respiratory dysfunction often develops later in the disease, but sleep-disordered breathing may appear earlier in some patients.

Respiratory concerns in myotonic dystrophy may include:

• Respiratory muscle weakness
• Obstructive sleep apnea
• Sleep-related hypoventilation
• Bulbar muscle dysfunction
• Aspiration risk
• Increased sensitivity to sedatives and anesthetic agents

Note: Patients with myotonic dystrophy require special caution around anesthesia, sedatives, analgesics, and respiratory depressants. Usual doses may cause prolonged respiratory depression or prolonged neuromuscular blockade. If surgery is required, careful postoperative monitoring is important.

How Muscular Dystrophy Affects Breathing

Muscular dystrophy affects breathing mainly by weakening the ventilatory pump. The lungs may initially be structurally normal, but the muscles responsible for breathing cannot generate enough force to move air effectively.

This is different from diseases such as pneumonia, asthma, or COPD, where the primary problem is in the lungs or airways. In muscular dystrophy, the main issue is often inadequate ventilation caused by muscle weakness.

Breathing depends on coordinated muscle activity. During inspiration, the diaphragm contracts and moves downward, expanding the thoracic cavity and drawing air into the lungs. The intercostal muscles and accessory muscles help expand the chest wall. During expiration, passive recoil normally moves air out at rest, but active expiration and coughing require strong expiratory muscles, especially the abdominal muscles.

As muscular dystrophy progresses, several problems may develop:

• The patient cannot take deep breaths.
• Tidal volume decreases.
• Minute ventilation becomes inadequate.
• The patient may breathe rapidly and shallowly.
• Cough becomes weak and ineffective.
• Secretions become harder to clear.
• Atelectasis and pneumonia become more likely.
• Carbon dioxide may rise because ventilation is inadequate.

Note: This pattern is often described as ventilatory pump failure. The respiratory system is not failing because the lungs cannot exchange oxygen and carbon dioxide at the alveolar level. Instead, the muscles cannot move enough air in and out of the lungs to support normal gas exchange.

Respiratory Muscle Weakness

Respiratory muscle weakness affects both inspiration and expiration. Inspiratory muscle weakness reduces the patient’s ability to generate adequate tidal volume and maintain normal alveolar ventilation. Expiratory muscle weakness reduces cough strength and secretion clearance.

Inspiratory Muscle Weakness

The diaphragm is the main muscle of inspiration. When the diaphragm weakens, the patient may have difficulty taking a deep breath, especially when lying flat. Orthopnea, or shortness of breath while lying down, can be an important symptom of diaphragmatic weakness.

Inspiratory muscle weakness may also cause shallow breathing, reduced vital capacity, sleep-related hypoventilation, and eventually daytime hypercapnia. Patients may rely more heavily on accessory muscles, but these muscles also become weak as muscular dystrophy progresses.

Expiratory Muscle Weakness

Expiratory muscle weakness affects cough. A strong cough requires the patient to inhale deeply, close the glottis, build pressure inside the chest, and then forcefully expel air. If the inspiratory muscles cannot take in enough air or the expiratory muscles cannot generate enough pressure, cough becomes weak.

A weak cough increases the risk of:

• Retained secretions
• Mucus plugging
• Atelectasis
• Recurrent infection
• Pneumonia
• Respiratory failure during acute illness

Note: This is why airway clearance is a major part of respiratory care in muscular dystrophy.

Airway Protection and Aspiration Risk

Muscular dystrophy can also affect the muscles involved in swallowing and airway protection. This is especially important when bulbar muscle dysfunction is present. Bulbar muscles help control swallowing, speech, airway closure, and protection of the lower airway.

When these muscles weaken, the patient may develop dysphagia, poor secretion control, weak gag reflex, choking, aspiration, or aspiration pneumonia. Aspiration occurs when food, liquid, saliva, or gastric contents enter the airway. In a patient with weak cough, aspirated material may be difficult to clear.

Assessment of airway protection should include:

• Swallowing ability
• Gag reflex
• Cough strength
• Secretion burden
• Mental status
• History of choking or aspiration
• Recurrent pneumonia
• Ability to cooperate with noninvasive ventilation

Note: If the patient cannot protect the airway, cannot clear secretions, or develops recurrent aspiration, noninvasive ventilation may not be safe or effective. In these cases, invasive airway support may need to be considered.

Respiratory Stages in Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is often described in respiratory stages. These stages help explain how ventilatory impairment develops over time and why early monitoring matters.

Stage 1: Normal Respiratory Function

In the first stage, respiratory function is still normal. The patient may already have a diagnosis of Duchenne muscular dystrophy, but there may be no major ventilatory impairment yet.

The goals during this stage are prevention, baseline testing, education, and routine follow-up. Patients and caregivers should understand that respiratory complications may develop later, even if breathing seems normal at the time of diagnosis.

Baseline testing may include:

• Oxygen saturation
• Forced vital capacity
• FEV₁
• Peak cough flow
• Maximum inspiratory pressure
• Maximum expiratory pressure

Note: These values are important because they provide a comparison point for future measurements. A declining trend can identify worsening respiratory muscle weakness before severe symptoms develop.

Stage 2: Adequate Ventilation With Ineffective Cough

In the second stage, the patient may still ventilate adequately, but cough becomes ineffective. This occurs because expiratory muscle weakness can impair secretion clearance before full ventilatory failure develops.

This stage is clinically important because retained secretions increase the risk of atelectasis and infection. The patient may appear stable while healthy but can deteriorate quickly during a respiratory infection because the weakened cough cannot clear mucus effectively.

At this stage, pulmonary follow-up often becomes more frequent, especially if the patient is older, wheelchair-bound, or has a declining vital capacity. Evaluation for dysphagia may also be appropriate because swallowing impairment increases aspiration risk.

Note: Airway clearance strategies may be introduced or intensified, including manually assisted coughing and mechanical insufflation-exsufflation.

Stage 3: Adequate Daytime Ventilation With Inadequate Nighttime Ventilation

In the third stage, daytime ventilation may still be adequate, but nighttime ventilation becomes impaired. This happens because sleep naturally reduces ventilatory drive and accessory muscle activity. A patient with weakened respiratory muscles may be able to compensate while awake but not during sleep.

Symptoms of nocturnal hypoventilation may include:

• Morning headaches
• Daytime sleepiness
• Fatigue
• Poor concentration
• Restless sleep
• Nighttime awakenings
• Orthopnea
• Shortness of breath
• Declining school or work performance

Note: Testing may include awake carbon dioxide levels, oxygen saturation, end-tidal carbon dioxide, home oximetry, capnography, or sleep studies. Nocturnal noninvasive ventilation is commonly recommended when symptoms or objective evidence of hypoventilation are present.

Stage 4: Inadequate Daytime and Nighttime Ventilation

In the fourth stage, respiratory muscle weakness has progressed to chronic ventilatory failure. The patient has inadequate ventilation during both the day and night. Carbon dioxide may remain elevated while awake, and the patient may require ventilatory support for longer periods.

At this point, management becomes more complex. Clinicians must assess whether noninvasive ventilation remains appropriate or whether invasive support through a tracheostomy is needed. The decision depends on ventilatory status, airway protection, secretion clearance, bulbar function, patient preference, and overall clinical stability.

Sleep-Related Breathing Problems

Sleep-related breathing problems are common in muscular dystrophy and may appear before daytime respiratory failure. This is especially important because patients may not report obvious shortness of breath during the day.

During sleep, breathing becomes more vulnerable because respiratory drive decreases, skeletal muscle tone falls, and accessory muscle activity is reduced. In a patient with respiratory muscle weakness, these normal changes can lead to hypoventilation.

Nocturnal Hypoventilation

Nocturnal hypoventilation means the patient does not breathe deeply or frequently enough during sleep to maintain normal gas exchange. Carbon dioxide rises, and oxygen saturation may fall. Over time, nocturnal hypoventilation can contribute to daytime symptoms and eventually daytime hypercapnia.

Common signs and symptoms include morning headache, excessive daytime sleepiness, poor sleep quality, fatigue, difficulty concentrating, and orthopnea. Some patients may also have nightmares, frequent awakenings, or unexplained decline in daytime function.

Obstructive Sleep Apnea

Some patients with muscular dystrophy also develop obstructive sleep apnea. This occurs when the upper airway repeatedly narrows or collapses during sleep. Upper airway muscle weakness, body position, obesity, and reduced muscle tone during sleep may contribute.

Obstructive sleep apnea and hypoventilation can occur together. This is one reason why sleep monitoring can be important. Positive airway pressure settings may need adjustment over time as weakness progresses.

Sleep Testing and Home Monitoring

Sleep-related breathing problems may be evaluated with polysomnography, home oximetry, capnography, or ventilator data from home devices. Formal sleep studies can be useful, but repeated laboratory testing may be difficult for patients with advanced disease.

Modern home positive airway pressure devices can provide useful data about usage, leaks, breathing events, pressures, and sometimes ventilation trends. This information can help clinicians adjust support and identify problems with adherence or effectiveness.

Assessment of Respiratory Function

Respiratory assessment in muscular dystrophy should focus on ventilation, cough strength, secretion clearance, and airway protection. Because the disease is progressive, trends over time are often more useful than a single measurement.

Vital Capacity and Forced Vital Capacity

Vital capacity and forced vital capacity are commonly used to monitor respiratory decline. These measurements reflect the patient’s ability to take a deep breath and exhale a large volume of air.

A declining vital capacity suggests worsening restrictive impairment from respiratory muscle weakness. It also indicates reduced ventilatory reserve. Patients with reduced vital capacity may be at greater risk for sleep-related hypoventilation, atelectasis, ineffective cough, and respiratory failure during illness.

Forced vital capacity may be monitored in seated and supine positions. A significant drop when lying down can suggest diaphragmatic weakness.

Maximum Inspiratory Pressure

Maximum inspiratory pressure, also called negative inspiratory force, measures the strength of the inspiratory muscles. The patient inhales as forcefully as possible against an occluded airway, and the pressure generated is measured.

More negative values indicate stronger inspiratory muscles. Less negative values suggest weakness and a reduced ability to sustain spontaneous ventilation. A declining maximum inspiratory pressure can support the need for closer monitoring or ventilatory assistance.

Maximum Expiratory Pressure and Peak Cough Flow

Maximum expiratory pressure reflects expiratory muscle strength. Peak cough flow measures how effectively the patient can generate airflow during coughing.

Low values suggest poor cough effectiveness and increased risk of secretion retention. These measurements can help determine when assisted cough techniques or mechanical insufflation-exsufflation may be needed.

Oxygen Saturation and Carbon Dioxide

Oxygen saturation is useful but can be misleading if interpreted alone. In early neuromuscular weakness, oxygen saturation may remain normal even when ventilation is declining. Later, oxygen desaturation may occur during sleep, infection, atelectasis, or severe hypoventilation.

Carbon dioxide measurement is especially important because rising carbon dioxide indicates inadequate ventilation. Carbon dioxide can be assessed with arterial blood gas analysis, venous blood gas in some settings, end-tidal carbon dioxide, transcutaneous carbon dioxide, or sleep-related monitoring.

A patient with muscular dystrophy can have acceptable oxygen saturation while retaining carbon dioxide. This is why oxygen alone should not be used as the primary treatment for ventilatory failure.

Airway Clearance in Muscular Dystrophy

Airway clearance is a major priority because weak cough can lead to retained secretions, atelectasis, infection, and respiratory failure. The patient may do well at baseline but deteriorate during a cold, flu, or pneumonia because secretions increase and cough strength is limited.

Manually Assisted Cough

Manually assisted cough involves applying external pressure to the abdomen or chest wall during the patient’s cough effort. This helps increase expiratory flow and move secretions. It requires coordination, training, and proper timing.

Caregivers may be taught manually assisted cough techniques for home use, especially if the patient has weak expiratory muscles but can still cooperate.

Mechanical Insufflation-Exsufflation

Mechanical insufflation-exsufflation is often called cough assist. It delivers a positive pressure breath to inflate the lungs, followed by a rapid shift to negative pressure. This simulates a cough and helps move secretions toward the upper airway.

This therapy can be especially useful when peak cough flow is low or maximum expiratory pressure is reduced. It may be used routinely or increased during respiratory infections. It can also help reduce the need for invasive airway management in selected patients who can protect their airway and tolerate the therapy.

Suctioning

Suctioning may be needed when secretions reach the upper airway and the patient cannot clear them independently. Suctioning can help remove mucus from the mouth, oropharynx, tracheostomy tube, or artificial airway. It should be performed carefully to avoid trauma, hypoxemia, or discomfort.

Lung Volume Recruitment

Lung volume recruitment, also called breath stacking or manual volume recruitment, may be used when vital capacity is reduced. The goal is to help expand the lungs, support chest wall mobility, and improve cough effectiveness.

This can be done with a resuscitation bag, mouthpiece, or ventilator-assisted technique depending on the patient’s condition and equipment. The purpose is not simply to raise oxygen saturation. It helps compensate for weak respiratory muscles and supports secretion mobilization.

Incentive Spirometry

Incentive spirometry is generally less effective when the main problem is respiratory muscle weakness. A patient with muscular dystrophy may not be able to generate enough inspiratory effort to use it effectively. Other techniques, such as lung volume recruitment and cough assist, are often more useful.

Noninvasive Ventilation

Noninvasive ventilation is a major treatment option for muscular dystrophy-related hypoventilation. It provides ventilatory support through a mask or other noninvasive interface without requiring an artificial airway.

Bilevel positive airway pressure is commonly used. Inspiratory positive airway pressure assists inspiration and helps increase tidal volume. Expiratory positive airway pressure helps maintain airway patency and may reduce obstructive events. The difference between inspiratory and expiratory pressure provides pressure support.

When Noninvasive Ventilation Is Used

Noninvasive ventilation may be indicated when the patient develops signs of hypoventilation, sleep-disordered breathing, rising carbon dioxide, declining forced vital capacity, oxygen desaturation during sleep, or symptoms of respiratory muscle fatigue.

Common indications include:

• Nocturnal hypoventilation
• Sleep-disordered breathing
• Morning headaches
• Daytime sleepiness
• Orthopnea
• Hypercapnia
• Declining vital capacity
• Weak inspiratory pressure
• Respiratory muscle fatigue

Note: Some guidance considers nocturnal ventilation when forced vital capacity falls below certain thresholds or when maximum inspiratory pressure becomes significantly reduced. However, noninvasive ventilation is generally started based on a combination of symptoms, measurements, sleep findings, and clinical judgment.

Benefits of Noninvasive Ventilation

Nocturnal noninvasive ventilation can improve daytime function in patients with muscular dystrophy. It may reduce respiratory muscle fatigue by supporting breathing during sleep. It can also improve ventilation, lower carbon dioxide, improve sleep quality, reduce morning headaches, and help the patient feel more rested during the day.

Noninvasive ventilation may also be useful after surgery, during respiratory infections, or after extubation in selected patients with chronic neuromuscular weakness.

Limitations of Noninvasive Ventilation

Noninvasive ventilation is not appropriate for every patient. It requires cooperation, adequate airway protection, manageable secretions, and a usable interface.

It may not be safe or effective when the patient has:

• Severe bulbar dysfunction
• Inability to protect the airway
• Excessive secretions
• Recurrent aspiration
• Severe facial weakness that prevents mask seal
• Worsening respiratory failure despite support
• Severe hypoxemia from pneumonia or other acute disease
• Reduced mental status that prevents safe use

Note: If these problems are present, intubation or tracheostomy ventilation may be required.

Invasive Ventilation and Tracheostomy

Invasive ventilation may become necessary when noninvasive support is no longer sufficient or safe. This may occur when the patient needs continuous ventilatory assistance, cannot manage secretions, cannot protect the airway, has severe bulbar dysfunction, or develops recurrent aspiration.

For long-term invasive support, ventilation is commonly provided through a tracheostomy. A tracheostomy can improve airway access and secretion management, but it also creates new responsibilities and risks.

Care considerations include:

• Tube care
• Humidification
• Suctioning
• Cuff management when applicable
• Infection prevention
• Ventilator alarms
• Emergency airway planning
• Communication support
• Caregiver training

Note: Tracheostomy decisions should be individualized. They should include the patient, family, medical team, respiratory therapists, and other care providers. Quality of life, goals of care, home support, and caregiver ability are all important.

Oxygen Therapy Considerations

Oxygen therapy must be used carefully in muscular dystrophy. The primary problem is often hypoventilation, not a lack of oxygen delivery from the lungs. Giving oxygen may raise SpO₂ while carbon dioxide continues to rise.

This can create a false sense of security. A patient may look better on the pulse oximeter while ventilation is still inadequate. If hypoventilation is the cause of respiratory failure, the treatment should focus on ventilatory assistance rather than oxygen alone.

Oxygen may still be appropriate in some situations, such as pneumonia, atelectasis, or other conditions causing hypoxemia. However, oxygen should be paired with careful assessment of ventilation and carbon dioxide when respiratory muscle weakness is present.

Scoliosis and Chest Wall Mechanics

Scoliosis is common in Duchenne muscular dystrophy and can worsen respiratory impairment. Progressive spinal curvature changes chest wall mechanics, limits lung expansion, and reduces the ability of the respiratory muscles to work efficiently.

Some patients undergo spinal fusion surgery to improve posture, comfort, and sitting stability. While evidence that spinal fusion directly improves pulmonary function is limited, it may help slow the rate of respiratory decline in some patients by improving posture and chest wall alignment.

Maintaining posture and chest wall mechanics is an important supportive goal. Seating, positioning, physical therapy, and orthopedic management can all contribute to respiratory comfort and function.

Respiratory Infections and Prevention

Respiratory infections can be especially dangerous for patients with muscular dystrophy. A mild infection can increase mucus production, raise ventilatory demand, worsen fatigue, and overwhelm a weak cough.

Prevention is an important part of care. Patients should receive appropriate immunizations, including influenza and pneumococcal vaccination when recommended. Caregivers should also understand early warning signs of respiratory decline.

Warning signs may include:

• Increased work of breathing
• Weak or ineffective cough
• Increased secretions
• Fever
• Reduced oxygen saturation
• Morning headaches
• Daytime sleepiness
• Confusion
• Poor oral intake
• Worsening fatigue
• Difficulty clearing mucus
• Signs of aspiration

Note: During illness, airway clearance may need to be increased. Noninvasive ventilation settings or duration may need adjustment. Some patients may need urgent evaluation if secretions cannot be cleared or carbon dioxide retention worsens.

Medication and Anesthesia Safety

Medication safety is important in muscular dystrophy. Patients may be vulnerable to respiratory depression from sedatives, opioids, anesthetic agents, and other medications that reduce ventilatory drive or muscle function.

Myotonic dystrophy is especially associated with increased sensitivity to anesthesia, sedatives, analgesics, and respiratory depressants. Usual doses may cause prolonged respiratory failure or prolonged neuromuscular blockade. Postoperative monitoring should be careful and prolonged when needed.

A key safety issue is the avoidance of succinylcholine in patients with chronic muscular conditions such as muscular dystrophy. It can cause serious complications and should generally be avoided. If intubation is required, medication selection should be done carefully, and the patient should be closely monitored.

Mechanical Ventilation Considerations

When mechanical ventilation is needed, settings should support ventilation while reducing the workload on weakened muscles. Many patients with muscular dystrophy have relatively preserved lung mechanics early, but weak muscles make it difficult to sustain spontaneous breathing.

Ventilatory support may include pressure-support ventilation, bilevel ventilation, assist/control ventilation, or other supportive modes depending on acuity, interface, patient effort, and clinical goals.

Important considerations include:

• Adequate tidal volume
• Adequate minute ventilation
• Carbon dioxide control
• Patient comfort
• Synchrony with the ventilator
• Leak management during noninvasive ventilation
• Appropriate trigger sensitivity
• Airway pressure monitoring
• Alarm settings
• Secretion management

Trigger sensitivity is especially important because weak patients may have difficulty initiating ventilator breaths if the trigger requires too much effort. Poor triggering can increase work of breathing and worsen fatigue.

Leaks are also important during noninvasive ventilation. Excessive leak can reduce delivered support, interfere with triggering, disturb sleep, and make therapy less effective.

Weaning Challenges

Weaning from mechanical ventilation can be difficult because muscular dystrophy is progressive. The patient may not have enough respiratory muscle strength or endurance to maintain spontaneous ventilation for long periods.

Readiness for weaning depends on more than oxygen saturation. The patient should have adequate ventilatory drive, inspiratory muscle strength, cough effectiveness, secretion control, stable acid-base status, and the ability to protect the airway.

A patient may pass a short assessment but fatigue after support is reduced. Weak cough and retained secretions may also lead to extubation failure or recurrent respiratory distress.

In some cases, noninvasive ventilation may be used after extubation to support breathing and reduce the risk of respiratory failure. This approach may be especially useful when chronic neuromuscular weakness is present and the patient can protect the airway.

Home Ventilation and Long-Term Care

Long-term management often extends into the home. Home ventilation requires planning, education, equipment support, and regular follow-up. The goal is to support breathing, prevent complications, and preserve the highest possible level of comfort and independence.

Home care planning may include:

• Noninvasive ventilator or portable ventilator
• Backup ventilator when needed
• Suction equipment
• Mechanical insufflation-exsufflation device
• Humidification
• Pulse oximeter
• Backup power plan
• Emergency contact plan
• Resuscitation equipment when appropriate
• Caregiver training
• Follow-up with pulmonary and neuromuscular specialists

Note: Caregivers may need to respond to alarms, troubleshoot masks or circuits, clear secretions, recognize respiratory distress, and know when emergency care is needed. Education should be repeated over time because patient needs change as the disease progresses.

Communication and Quality of Life

Respiratory care in muscular dystrophy is not only about measurements and equipment. Communication, comfort, sleep quality, mobility, nutrition, emotional support, and independence all matter.

Patients using tracheostomy ventilation may have difficulty speaking. Speaking valves, specialized tracheostomy tubes, ventilator adjustments, or alternative communication tools may help. Patients using noninvasive ventilation may need mask adjustments, humidification, skin protection, and support with adherence.

Quality of life discussions should be ongoing. Because muscular dystrophy is progressive, goals of care may change over time. Patients and families should be included in decisions about ventilation, tracheostomy, hospitalization, home support, and emergency planning.

Role of the Respiratory Therapist

Respiratory therapists play an important role in the care of patients with muscular dystrophy. Their responsibilities may include assessment, airway clearance, ventilator management, patient education, and home care support.

Important respiratory therapy responsibilities include:

• Monitoring oxygenation and ventilation
• Measuring vital capacity and inspiratory pressure
• Assessing cough strength and secretion clearance
• Supporting airway clearance techniques
• Setting up and troubleshooting noninvasive ventilation
• Monitoring ventilator synchrony and comfort
• Educating patients and caregivers
• Recognizing signs of hypoventilation
• Helping plan safe transitions from hospital to home

Note: Because muscular dystrophy is progressive, respiratory therapy is not a one-time intervention. It requires ongoing reassessment and individualized care.

Muscular Dystrophy Practice Questions

1. What is muscular dystrophy?
Muscular dystrophy is a group of inherited disorders that cause progressive weakness and loss of skeletal muscle.

2. Why is muscular dystrophy important in respiratory care?
It can weaken the muscles needed for breathing, coughing, secretion clearance, swallowing, and airway protection.

3. In muscular dystrophy, are the lungs usually the primary problem early in the disease?
No. The lungs may be structurally normal early on, but the ventilatory muscles become too weak to move air effectively.

4. What does it mean that muscular dystrophy is a myopathic disease?
It means the primary problem is in the muscle itself rather than in the nerves that send signals to the muscle.

5. Why can a patient with muscular dystrophy develop ventilatory failure even if the lungs are normal?
The respiratory muscles may become too weak to generate adequate tidal volume and minute ventilation.

6. Which major muscle of inspiration is affected as muscular dystrophy progresses?
The diaphragm can become weakened as the disease progresses.

7. What happens when the inspiratory muscles become weak?
The patient has difficulty taking deep breaths, maintaining tidal volume, and sustaining adequate ventilation.

8. What happens when the expiratory muscles become weak?
The patient develops a weak cough and has difficulty clearing secretions.

9. Why is a weak cough dangerous in muscular dystrophy?
A weak cough allows secretions to accumulate, increasing the risk of mucus plugging, atelectasis, infection, and pneumonia.

10. What is ventilatory pump failure?
Ventilatory pump failure occurs when the muscles that move air in and out of the lungs cannot generate enough force for adequate ventilation.

11. Why is oxygen alone not the main treatment for hypoventilation in muscular dystrophy?
Oxygen may improve SpO₂ but does not correct inadequate ventilation or carbon dioxide retention.

12. What gas abnormality suggests hypoventilation in muscular dystrophy?
An elevated carbon dioxide level suggests hypoventilation.

13. What is one common early sign of nocturnal hypoventilation?
Morning headaches can be an early sign of nocturnal hypoventilation.

14. Why does hypoventilation often appear first during sleep?
During sleep, ventilatory drive and accessory muscle activity decrease, making weak respiratory muscles less able to maintain ventilation.

15. What are common symptoms of sleep-related hypoventilation in muscular dystrophy?
Symptoms include morning headaches, daytime sleepiness, fatigue, poor concentration, restless sleep, and orthopnea.

16. What is Duchenne muscular dystrophy?
Duchenne muscular dystrophy is a progressive genetic muscle-wasting disorder caused by mutations in the dystrophin gene.

17. What protein is absent or abnormal in Duchenne muscular dystrophy?
Dystrophin is absent or abnormal.

18. Why does Duchenne muscular dystrophy primarily affect males?
It is inherited as an X-linked recessive disorder.

19. What type of muscle weakness commonly appears early in Duchenne muscular dystrophy?
Proximal muscle weakness commonly appears early.

20. What gait abnormality may be seen in Duchenne muscular dystrophy?
A waddling gait may be seen due to proximal muscle weakness.

21. Around what age do many children with Duchenne muscular dystrophy require a wheelchair?
Many require a wheelchair by about 12 years of age.

22. Why does respiratory decline often become more noticeable around wheelchair dependence?
By that time, overall muscle weakness has progressed enough to significantly affect respiratory muscles.

23. What respiratory complication can result from retained secretions?
Retained secretions can lead to atelectasis, mucus plugging, infection, and pneumonia.

24. How can pneumonia worsen respiratory status in muscular dystrophy?
Pneumonia increases the workload on already weakened respiratory muscles and can precipitate respiratory failure.

25. What has improved survival in Duchenne muscular dystrophy?
The widespread use of noninvasive ventilation has helped improve survival.

26. Which type of muscular dystrophy is closely related to Duchenne muscular dystrophy but usually milder?
Becker muscular dystrophy is closely related but generally milder and slower progressing.

27. What genetic protein abnormality is associated with Becker muscular dystrophy?
Becker muscular dystrophy is associated with abnormalities in dystrophin.

28. Can Becker muscular dystrophy cause respiratory problems?
Yes. Respiratory involvement can occur later in the disease course as muscle weakness progresses.

29. What is myotonic dystrophy?
Myotonic dystrophy is an inherited muscular dystrophy characterized by progressive weakness and delayed muscle relaxation.

30. What is myotonia?
Myotonia is delayed relaxation of a muscle after contraction.

31. What is the most common muscular dystrophy in adults?
Myotonic dystrophy is the most common muscular dystrophy in adults.

32. What inheritance pattern is associated with myotonic dystrophy?
Myotonic dystrophy is inherited as an autosomal dominant disorder.

33. Name one systemic complication associated with myotonic dystrophy.
Cardiac conduction abnormalities can occur in myotonic dystrophy.

34. How can bulbar muscle dysfunction affect breathing in muscular dystrophy?
It can impair swallowing and airway protection, increasing the risk of aspiration.

35. Why are patients with myotonic dystrophy at increased risk during anesthesia?
They may be unusually sensitive to sedatives, analgesics, anesthetic agents, and respiratory depressants.

36. What complication can usual doses of sedatives cause in myotonic dystrophy?
Usual doses may cause respiratory failure or prolonged respiratory depression.

37. Why should postoperative monitoring be careful in patients with myotonic dystrophy?
They may have prolonged respiratory weakness or sensitivity to medications after surgery.

38. What medication should generally be avoided in patients with chronic muscular conditions such as muscular dystrophy?
Succinylcholine should generally be avoided.

39. What is the first respiratory stage of Duchenne muscular dystrophy?
The first stage is normal respiratory function.

40. What is the main goal during the first respiratory stage of Duchenne muscular dystrophy?
The main goal is prevention, education, baseline testing, and routine follow-up.

41. Why are baseline respiratory measurements important in muscular dystrophy?
They allow clinicians to compare future results and identify respiratory decline early.

42. Which pulmonary function measurement reflects the patient’s ability to take a deep breath and exhale a large volume of air?
Vital capacity or forced vital capacity reflects this ability.

43. What does a declining vital capacity suggest in muscular dystrophy?
It suggests worsening respiratory muscle weakness and reduced ventilatory reserve.

44. What does maximum inspiratory pressure measure?
It measures inspiratory muscle strength.

45. What is another name for maximum inspiratory pressure?
Maximum inspiratory pressure is also called negative inspiratory force.

46. What do more negative maximum inspiratory pressure values indicate?
More negative values indicate stronger inspiratory muscles.

47. What does maximum expiratory pressure assess?
It assesses expiratory muscle strength.

48. What does peak cough flow help evaluate?
It helps evaluate how effectively the patient can cough and clear secretions.

49. What does a low peak cough flow suggest?
It suggests weak cough, poor secretion clearance, and increased risk of retained mucus.

50. Why can normal oxygen saturation be misleading in muscular dystrophy?
The patient may have normal SpO₂ while still retaining carbon dioxide from inadequate ventilation.

51. What is the second respiratory stage of Duchenne muscular dystrophy?
The second stage is adequate ventilation with an ineffective cough.

52. Why is the second stage clinically important?
Secretion clearance becomes impaired even though ventilation may still be adequate.

53. What should be assessed if a patient with muscular dystrophy has swallowing difficulty?
The patient should be assessed for dysphagia and aspiration risk.

54. What is the third respiratory stage of Duchenne muscular dystrophy?
The third stage is adequate daytime ventilation with inadequate nighttime ventilation.

55. What treatment is commonly recommended for nocturnal hypoventilation?
Nocturnal noninvasive positive-pressure ventilation is commonly recommended.

56. What is the fourth respiratory stage of Duchenne muscular dystrophy?
The fourth stage is inadequate ventilation during both the day and night.

57. What may a patient require during the fourth respiratory stage?
The patient may require more continuous ventilatory assistance and closer monitoring.

58. Why is carbon dioxide monitoring important in advanced muscular dystrophy?
It helps identify inadequate ventilation and carbon dioxide retention.

59. What is obstructive sleep apnea?
Obstructive sleep apnea is repeated narrowing or collapse of the upper airway during sleep.

60. Why can obstructive sleep apnea occur in muscular dystrophy?
Upper airway muscle weakness and reduced muscle tone during sleep can contribute to airway collapse.

61. What is polysomnography used for in muscular dystrophy?
It is used to evaluate sleep-disordered breathing, nocturnal hypoventilation, oxygen desaturation, and sleep apnea.

62. How can home oximetry help in muscular dystrophy?
It can detect oxygen desaturation during sleep that may suggest nocturnal breathing problems.

63. Why may capnography be useful during sleep monitoring?
It can help detect carbon dioxide retention from hypoventilation.

64. What is one reason positive airway pressure settings may need adjustment over time?
Respiratory muscle weakness can progress, changing the patient’s ventilatory needs.

65. What is noninvasive ventilation?
Noninvasive ventilation provides ventilatory support through a mask or other noninvasive interface without an artificial airway.

66. What type of noninvasive support is commonly used in muscular dystrophy?
Bilevel positive airway pressure is commonly used.

67. How does inspiratory positive airway pressure help?
It assists inspiration, increases tidal volume, and reduces the work required from weakened inspiratory muscles.

68. How does expiratory positive airway pressure help?
It helps maintain airway patency and may reduce obstructive events during sleep.

69. What does pressure support refer to in bilevel ventilation?
Pressure support is the difference between inspiratory pressure and expiratory pressure.

70. Why can nocturnal ventilation improve daytime function?
It rests fatigued respiratory muscles during sleep and improves ventilation.

71. Should noninvasive ventilation always be started before clear signs of hypoventilation?
No. It is generally started when there is evidence of hypoventilation, sleep-disordered breathing, or declining respiratory mechanics.

72. What is one limitation of noninvasive ventilation?
It may not be appropriate if the patient cannot protect the airway or manage secretions.

73. Name one condition that may make noninvasive ventilation unsafe.
Severe bulbar dysfunction may make noninvasive ventilation unsafe.

74. When may intubation or tracheostomy ventilation be needed?
It may be needed when noninvasive ventilation fails, airway protection is poor, or secretions cannot be managed.

75. Why is respiratory management in muscular dystrophy proactive rather than reactive?
Respiratory decline is progressive, and early monitoring can prevent complications before crisis occurs.

76. What is the main purpose of mechanical insufflation-exsufflation?
It helps simulate a cough by delivering positive pressure followed by negative pressure to move secretions out of the airway.

77. When is mechanical insufflation-exsufflation especially useful?
It is especially useful when peak cough flow is low or expiratory muscle strength is reduced.

78. What is manually assisted cough?
Manually assisted cough is a technique in which external pressure is applied to help increase expiratory flow during coughing.

79. Why may suctioning be needed in muscular dystrophy?
Suctioning may be needed when the patient cannot clear secretions independently.

80. What is lung volume recruitment?
Lung volume recruitment is a technique used to help expand the lungs and improve cough effectiveness in patients with reduced vital capacity.

81. Why is incentive spirometry often less effective in muscular dystrophy?
It requires inspiratory effort that patients with respiratory muscle weakness may not be able to generate effectively.

82. How can scoliosis worsen respiratory function in Duchenne muscular dystrophy?
Scoliosis can alter chest wall mechanics, limit lung expansion, and worsen respiratory insufficiency.

83. What is one reason spinal fusion may be considered in Duchenne muscular dystrophy?
It may help improve posture, comfort, and sitting stability.

84. Does spinal fusion clearly improve pulmonary function in Duchenne muscular dystrophy?
Clear evidence that spinal fusion directly improves pulmonary function is limited.

85. Why are respiratory infections especially dangerous in muscular dystrophy?
They increase secretion burden and ventilatory workload, which can overwhelm weakened respiratory muscles.

86. Which vaccinations can help reduce respiratory infection risk in muscular dystrophy?
Influenza and pneumococcal vaccinations can help reduce respiratory infection risk.

87. What should caregivers be trained to recognize?
Caregivers should recognize signs of respiratory decline, secretion retention, hypoventilation, and respiratory distress.

88. What is one sign that a respiratory infection is becoming dangerous in muscular dystrophy?
Difficulty clearing mucus can indicate worsening risk during infection.

89. What should home ventilation planning include?
It should include ventilatory equipment, suction devices, backup power, emergency plans, and caregiver training.

90. Why is backup power important for home ventilatory support?
Backup power helps maintain respiratory support during power outages.

91. What should be monitored after ventilatory support begins?
Comfort, synchrony, tidal volume, minute ventilation, oxygen saturation, carbon dioxide, and signs of fatigue should be monitored.

92. Why are ventilator alarms important?
They help detect problems such as disconnection, high pressure, low pressure, apnea, or inadequate ventilation.

93. Why is leak management important during noninvasive ventilation?
Excessive leak can reduce delivered support, interfere with triggering, and make ventilation less effective.

94. Why is trigger sensitivity important for patients with muscular dystrophy?
Weak patients may have difficulty triggering breaths if the ventilator requires too much effort.

95. Why can weaning from mechanical ventilation be difficult in muscular dystrophy?
The underlying muscle weakness is progressive, so the patient may lack the strength and endurance to sustain spontaneous breathing.

96. Why is oxygenation alone not enough to determine weaning readiness?
The patient also needs adequate ventilation, muscle strength, cough effectiveness, secretion control, and stable carbon dioxide levels.

97. What can cause extubation failure in muscular dystrophy?
Weak cough, secretion retention, respiratory muscle fatigue, and poor airway protection can cause extubation failure.

98. How may noninvasive ventilation be used after extubation?
It may be used to support breathing and reduce the risk of respiratory failure in selected patients.

99. Why is communication support important for patients with tracheostomies?
A tracheostomy can interfere with normal speech, so speaking valves or other communication strategies may be needed.

100. What is the central respiratory care focus in muscular dystrophy?
The focus is supporting ventilation, assisting cough, managing secretions, protecting the airway, and preventing respiratory complications.

Final Thoughts

Muscular dystrophy can affect far more than limb strength. As the disease progresses, weakness of the diaphragm, chest wall muscles, expiratory muscles, and bulbar muscles can lead to ineffective cough, retained secretions, aspiration risk, nocturnal hypoventilation, and chronic respiratory failure.

The most important respiratory care priorities are early monitoring, prevention of infection, airway clearance, recognition of sleep-related breathing problems, and timely ventilatory support.

Oxygen alone does not correct ventilatory pump failure, so treatment must focus on ventilation, cough assistance, secretion management, and airway protection. With proactive care, many complications can be reduced and quality of life can be better supported.